knowledge -WSS

knowledge

author：focus 2025-10-02 22:40:07 - browse：46

Most everything is looking up for Orexo, the company reported on its second quarter earnings call on Tuesday. That is, everything but its digital therapies pipeline.

The Swedish pharmaceutical company, which makes almost all of its money from U.S. sales of its drug for opioid dependence, notched a number of important victories in the quarter: It successfully defended its patents in a case against Sun Pharmaceuticals, it resolved a packaging issue that was holding up the approval of its long-acting rescue medication, and it grew revenues for Zubsolv, its most important product. The company trimmed its losses to 12.6 million SEK, or $1.2 million, and executives reported that with fewer one-time expenses on the horizon, profitability was “in sight.”

“We are at an exciting turning point for the company and I hope our self confidence and optimism is something that you can share,” CEO Nikolaj Sørensen said on the company’s earnings call while cautioning that “there’s a lot more work to be done.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

knowledge

WSS

Doctor appointment wait times are getting worse

'CMA Fest' 2023: How to watch, who is performing and more

Extensive review finds private equity owners jack up cost of care

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

How a Boston hospital is priming medical residents to use GPT

Are infertility treatments 'essential' during the Covid

knowledge

knowledge

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

RaDonda Vaught case: a double standard for nurses, physicians

New air purifier tech could be key to improving indoor air quality

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Sports medicine is finally prioritizing gender equality

Doctor appointment wait times are getting worse

Drug repurposing or repositioning? The language matters

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Cancer drug shortages should be causing more outrage

Bacterial infection may be ‘key event’ in endometriosis, study says

hotspot

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Listen: PBM conflicts, RSV vaccines, & the future of flu season

New case study details death in closely watched Alzhiemer's trial

Dementia risk linked to living in disadvantaged areas: Study

Bacterial infection may be ‘key event’ in endometriosis, study says

Option Care buys Amedisys in $3.6 billion home care deal

knowledge

focus

explore

knowledge